Major Ingredients

Amoxicillin BP + Clavulanic acid USP; (400mg + 57.5mg) /5ml Suspension.

Major Functionality

Co-amoxiclav oral preparation is indicated for the short-term treatment of bacterial infections which is given below-upper respiratory-tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media., Lower respiratory-tract infections (e.g. acute & chronic bronchitis, bronchopneumonia). Skin and soft tissue infections (cellulitis, animal bites) Genito-urinary-tract infections e.g. (cystitis, urethritis, pyelonephritis), bone & Joint infections e.g. osteomyelitis. other infections e.g. Septic abortion, purperal sepsis, intra-abdominal sepsis, etc.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.